The Internationalization Trend of the Pharmaceutical and Healthcare Industry

With global population aging and the upgrading of health consumption, the pharmaceutical and healthcare industry is becoming a strategic growth driver for the world economy. In particular, the Asian market—where traditional Chinese medicine is increasingly integrated with modern medicine, and where health foods and functional beverages are on the rise—offers abundant opportunities for industry development.

Against this backdrop, the demand for international pharmaceutical cooperation is growing stronger. Whether it is the R&D of innovative drugs, the production of generics, or the cross-border sales of health foods, enterprises must rely on international platforms to achieve resource integration and market expansion.

Chiundo Co., Ltd., with its Pharmaceutical Wholesale License issued by the Japanese government, is legally authorized to engage in the import and export of pharmaceuticals, Kampo medicines, and medical devices. At the same time, the company integrates cross-border e-commerce, logistics, and packaging design services to provide partners with comprehensive end-to-end solutions. Furthermore, leveraging its international expertise in GMP consulting and trademark licensing, Chiundo supports enterprises in building a complete ecosystem covering R&D, production, and sales.

Looking ahead, the pharmaceutical and healthcare industry will increasingly emphasize cross-border collaboration and the integration of international standards. What enterprises need is not just market access, but a reliable long-term cooperation platform. Guided by its values of Professionalism, Efficiency, and Compliance, Chiundo is committed to becoming a strategic bridge for global partners.